Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Cecilia Linde Added: 1 year ago
In this short interview, Dr Cecilia Linde (Karolinska University, SE) shares the findings of the CCM HFpEF Study. Originally presented at Heart Failure 22, this study aimed to evaluate the safety and efficacy of cardiac contractility modulation therapy in heart failure patients with preserved ejection fraction (HFpEF). Discussion Points: 1. Study Background 2. Study Design & Patient Population 3… View more
Improving Cardiovascular Health through Innovation The Cardiovascular Research Foundation (CRF) strives to improve the quality of life for patients with cardiovascular disease. Investigate CRF investigates early-stage technologies. We consult for new device and drug therapies, develop unique experimental models, and offer a full range of histopathology services and advanced cardiac imaging. … View more
Author(s): Julia Lurz Added: 1 year ago
Dr Julia Lurz (Heart Center Leipzig, Leipzig, DE) joins us at HRS 22 to discuss the Mental-AF Trial. This study aimed to investigate if app-based mental training can impact the occurrence of atrial fibrillation episodes after catheter ablation for AF. Discussion points: 1. Aim of this study 2. Function of the app 3. Patient population and study design 4. Key findings 5. Impact on practice 6… View more
Job title: Consultant Cardiologist & Electrophysiologist
Mauro Lencioni is a cardiologist at the Queen Elizabeth Hospital, Birmingham. His interests are the treatment of cardiac arrhythmias and the effects of arrhythmia symptoms on quality of life. View more
Author(s): Demosthenes G Katritsis Added: 3 years ago
Although the exact circuit of atrioventricular nodal re-entrant tachycardia (AVNRT) still eludes us, AVNRT is the most common regular arrhythmia in humans, and therefore the most commonly encountered during ablation attempts for regular tachycardias.1–4 Catheter ablation for AVNRT is the current treatment of choice in symptomatic patients. It reduces arrhythmia-related hospitalisations and costs,… View more
The Heart Failure Association (HFA) of the ESC has a mission to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research. ) is an independent, non-profit organisation. Its members and decision-makers are busy healthcare professionals who volunteer their time and… View more
The European Heart Rhythm Association (EHRA) is a registered branch of the European Society of Cardiology (ESC). Its aim is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death. EHRA promotes science and education in the field of cardiac arrhythmias with a special focus on AF. Besides patient engagement programmes… View more
Job title: Cardiovascular Disease and Hospice & Palliative Medicine Fellow
Dr Sarah Godfrey, MD, MPH is acardiovascular disease and hospice and palliative medicine fellow at UT Southwestern Medical Center. She grew up in New Jersey, studied African and African American Studies at Harvard University, and then did the majority of her medical training at Columbia University (postbac program, medical school, MPH, and internal medicine residency). Her research focus is in… View more
Author(s): Nicolas M Van Mieghem Added: 5 years ago
An analysis of the late-breaking trials from ACC 2019 presented by Dr Nicolas van Mieghem (Erasmus MC, Rotterdam, NL). Filmed on site at ACC 2019 by Radcliffe Cardiology Topics: 00:19 - Apple Heart Study 01:50 - PARTNER 3 Trial 03:44 - CoreValve Low Risk Study 06:26 - STS/TVT Registry Sub-Analysis 07:32 - COAPT Quality of Life Analysis 07:43 - COAPT Echo Sub-Analysis 08:14 - AUGUSTUS… View more